Bamco Inc. NY lessened its holdings in Endava plc (NYSE:DAVA - Free Report) by 20.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 674,261 shares of the company's stock after selling 177,335 shares during the period. Bamco Inc. NY owned about 1.14% of Endava worth $20,835,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors also recently bought and sold shares of the business. Alyeska Investment Group L.P. increased its position in shares of Endava by 80.6% during the fourth quarter. Alyeska Investment Group L.P. now owns 1,806,044 shares of the company's stock worth $55,807,000 after purchasing an additional 805,903 shares in the last quarter. Kerrisdale Advisers LLC grew its holdings in shares of Endava by 18.7% during the fourth quarter. Kerrisdale Advisers LLC now owns 359,942 shares of the company's stock worth $11,122,000 after buying an additional 56,781 shares in the last quarter. Sompo Asset Management Co. Ltd. raised its position in shares of Endava by 10.1% in the fourth quarter. Sompo Asset Management Co. Ltd. now owns 15,680 shares of the company's stock valued at $485,000 after buying an additional 1,440 shares during the last quarter. T. Rowe Price Investment Management Inc. lifted its stake in shares of Endava by 7.2% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 2,549,317 shares of the company's stock worth $78,774,000 after buying an additional 171,048 shares in the last quarter. Finally, Arvin Capital Management LP acquired a new position in Endava during the fourth quarter worth about $5,960,000. Institutional investors and hedge funds own 62.23% of the company's stock.
Analyst Ratings Changes
A number of brokerages have issued reports on DAVA. Susquehanna cut their target price on Endava from $55.00 to $50.00 and set a "positive" rating for the company in a research note on Friday, February 21st. Needham & Company LLC reduced their target price on shares of Endava from $43.00 to $38.00 and set a "buy" rating on the stock in a research note on Friday, February 21st. Finally, Morgan Stanley increased their price target on shares of Endava from $33.00 to $35.00 and gave the company an "equal weight" rating in a research note on Friday, January 31st. Four equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat.com, Endava currently has a consensus rating of "Moderate Buy" and an average target price of $38.51.
Read Our Latest Stock Report on DAVA
Endava Price Performance
Shares of Endava stock traded up $0.25 during trading on Wednesday, reaching $19.02. The company's stock had a trading volume of 428,006 shares, compared to its average volume of 485,353. The business has a 50 day moving average price of $19.72 and a 200-day moving average price of $26.10. The company has a market capitalization of $1.12 billion, a P/E ratio of 172.91, a price-to-earnings-growth ratio of 2.26 and a beta of 1.25. The company has a quick ratio of 1.90, a current ratio of 1.90 and a debt-to-equity ratio of 0.21. Endava plc has a 12-month low of $16.60 and a 12-month high of $34.94.
Endava (NYSE:DAVA - Get Free Report) last issued its earnings results on Thursday, February 20th. The company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.32 by ($0.18). Endava had a return on equity of 0.89% and a net margin of 0.74%. The company had revenue of $250.63 million for the quarter, compared to analyst estimates of $197.33 million. As a group, sell-side analysts anticipate that Endava plc will post 0.57 EPS for the current year.
Endava Profile
(
Free Report)
Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.
Further Reading

Before you consider Endava, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Endava wasn't on the list.
While Endava currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.